CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 80.95 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $9.390 million which missed the analyst consensus estimate of $10.181 million by 7.77 percent. This is a 6.57 percent increase over sales of $8.811 million the same period last year.